当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
BEXSERO, Meningococcal Group B Vaccine
申请企业
GlaxoSmithKline Biologicals
药品名称
BEXSERO, Meningococcal Group B Vaccine
承诺描述
To conduct study V72_72 of BEXSERO among persons 10 years through 25 years of age in the US to confirm effectiveness against a panel of diverse Neisseria meningitidis serogroup B strains.
承诺状态描述
The study completion date has passed and the study has not yet been completed.